Adult Surviving Sepis Campaign Guidelines (Hour-1 Bundle)
Children's Surviving Sepsis Campaign Guidelines
Adult ICU Liberation Guidelines and Bundle (A-F)
Management of Adults with COVID-19
New User? Sign Up Free
SCCM is updating its SCCM Connect Community. Access to SCCM Connect may be limited until April 23.
Crit Care Med 2017; 45(9):e877-e915
Safe Medication Use in the ICU
Citation: Crit Care Med 2017; 45(9):e877-e915
Clinical Practice Guideline: Safe Medication Use in the ICU provides ICU clinicians with evidence-based guidance on safe medication use practices for the critically ill. This guideline evaluates the ICU environment as a risk for medication-related events and the environmental changes that are possible to improve safe medication use. Prevention strategies for medication-related events are reviewed by medication use process node (prescribing, distribution, administration, monitoring). Detailed considerations to an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted is the need for future research for safe medication practices that is specific to critically ill patients.
Guideline Type: Clinical
Executive Summary: Clinical Practice Guideline Safe Medication Use in the ICU
Toolkit to Enhance Medication Error (ME) and Adverse Drug Event (ADE) Surveillance in the ICU
Read Full Guideline
A complete list of the guidelines authors and contributors is available within the published manuscript.